IL10 and rheumatoid arthritis: In rheumatoid arthritis, patients significantly altered serum cytokines, reducing TNF-α, IL-15, and RANTES (Regulated on activation, normal T expressed and secreted), while increasing IL-10, which correlated with clinical improvement, especially in treatment responders [32].